FDA Panel to Decide on Novavax COVID Vaccine
TUESDAY, June 7, 2022 (HealthDay News) — A U.S. Food and Drug Administration vaccine advisory panel will weigh whether to recommend the emergency use of Novavax’s COVID-19 vaccine on Tuesday. The decision will be based on clinical trial data the company released in January, when it first filed for approvalContinue Reading